Liqun Zou
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies (NCT04684472) | Liqun Zou | 2021-03-17 |
Track Liqun Zou automatically
Every clearance here is in the API, with alerts when new ones post.